跳至主要内容
临床试验/IRCT20201213049705N1
IRCT20201213049705N1已完成3 期

Evaluation of the Efficacy and Safety of Intra-Tracheal Administration of Beraksurf in Comparison with Survanta and Curosurf in Neonates with Respiratory Distress Syndrome: A Three-Arm Randomized Clinical Trial

Tehran University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 2 months(—)
性别
All

入选标准

  • Neonates with RDS
  • Premature infants with =25 to 34 weeks of gestation
  • Included during the first 8 hours of birth
  • required more than 30% FIO2

排除标准

  • severe asphyxia at birth with a 5th minute Apgar score of less than 6
  • severe congenital anomalies such as heart disease and life-threatening abnormalities
  • Rupture of membranes for longer than 2-weeks
  • Multiple anomalies
  • septicemia,
  • respiratory failure for reasons other than RDS

研究者

相似试验